Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:54:33 EDT Sat 11 Apr 2026
Enter Symbol
or Name
USA
CA



Z:ABT - ABBOTT LABORATORIES - https://www.abbott.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ABT - Z4.0100.00·100.304.9100.30-2.44-2.411,944.71,190,73082,445102.71  102.77  99.34139.05  100.87519:58:45Apr 0915 min RT 2¢

Recent Trades - Last 10 of 82445
Time ETExPriceChangeVolume
19:58:45Z100.26-2.4610
19:57:18Z100.28-2.441
19:54:49Z100.2588-2.46122
19:52:03Z100.29-2.431
19:48:24Z100.25-2.471
19:45:56Z100.29-2.433
19:44:10Z100.29-2.434
19:36:15Z100.29-2.431
19:30:37Z100.29-2.431
19:30:20Z100.29-2.435

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-04-09 09:00U:ABTNews ReleaseNew survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
2026-03-30 09:00U:ABTNews ReleaseAbbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR(TM) platform
2026-03-26 09:00U:ABTNews ReleaseAbbott hosts conference call for first-quarter earnings
2026-03-24 08:00U:ABTNews ReleaseJohn Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard(TM) tests, encouraging colon cancer screening
2026-03-23 08:50U:ABTNews ReleaseAbbott completes acquisition of Exact Sciences
2026-03-20 09:00U:ABTNews ReleaseAbbott acquisition of Exact Sciences set to close on March 23, 2026
2026-03-12 08:00U:ABTNews ReleaseLandmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
2026-03-11 11:00U:ABTNews ReleaseAbbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
2026-02-20 11:38U:ABTNews ReleaseAbbott declares 409th consecutive quarterly dividend
2026-02-06 08:00U:ABTNews ReleaseLate-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
2026-01-22 07:30U:ABTNews ReleaseAbbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
2026-01-20 09:00U:ABTNews ReleaseAbbott receives CE Mark for the TactiFlex(TM) Duo Ablation Catheter to treat patients with abnormal heart rhythms
2026-01-07 09:00U:ABTNews ReleaseAbbott's FreeStyle Libre 3 Plus Now Covered Across Canada
2026-01-05 16:30U:ABTNews ReleaseAbbott hosts conference call for fourth-quarter earnings
2026-01-05 09:05U:ABTNews ReleaseAbbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
2025-12-22 09:00U:ABTNews ReleaseAbbott's Volt(TM) Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
2025-12-18 09:00U:ABTNews ReleaseAbbott's Amplatzer Piccolo(TM) Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart
2025-12-12 10:26U:ABTNews ReleaseAbbott increases quarterly dividend for 54th consecutive year
2025-12-08 09:00U:ABTNews ReleaseAbbott's Lingo(TM) Now on Android(TM), Expanding Access to Real-Time Glucose Data
2025-12-06 20:45U:ABTNews ReleaseUniversity of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives